Predilife S.A [ALPRE] vs Eurofins Scientific [ERF] Detailed Stock Comparison
Predilife S.A
Euronext
Loading...
Eurofins Scientific
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Predilife S.A wins in 4 metrics, Eurofins Scientific wins in 10 metrics, with 0 ties. Eurofins Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Predilife S.A | Eurofins Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 28.82 | N/A |
| Price-to-Book Ratio | N/A | 3.39 | N/A |
| Debt-to-Equity Ratio | -1.16 | 88.06 | Predilife S.A |
| PEG Ratio | N/A | 18.85 | N/A |
| EV/EBITDA | -4.14 | 10.41 | Predilife S.A |
| Profit Margin (TTM) | 97.76% | 6.05% | Predilife S.A |
| Operating Margin (TTM) | -558.18% | 13.16% | Eurofins Scientific |
| EBITDA Margin (TTM) | N/A | 13.16% | N/A |
| Return on Equity | -4,653.75% | 8.68% | Eurofins Scientific |
| Return on Assets (TTM) | -73.10% | 5.46% | Eurofins Scientific |
| Free Cash Flow (TTM) | $-3.73M | $790.50M | Eurofins Scientific |
| Dividend Yield | N/A | 1.82% | N/A |
| 1-Year Return | -28.69% | 25.78% | Eurofins Scientific |
| Price-to-Sales Ratio (TTM) | 25.95 | 1.68 | Eurofins Scientific |
| Enterprise Value | $16.51M | $14.89B | Eurofins Scientific |
| EV/Revenue Ratio | 33.47 | 2.08 | Eurofins Scientific |
| Revenue per Share (TTM) | $0 | $39 | Eurofins Scientific |
| Earnings per Share (Diluted) | $-1.19 | $2.27 | Eurofins Scientific |
| Beta (Stock Volatility) | 0.38 | 0.77 | Predilife S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Predilife S.A vs Eurofins Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Predilife S.A | 0.00% | -4.52% | -6.11% | -8.40% | -11.05% | -5.06% |
| Eurofins Scientific | 1.16% | 0.82% | 11.36% | 18.42% | 28.90% | 36.27% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Predilife S.A | -28.69% | -44.59% | -54.32% | -63.66% | -63.66% | -63.66% |
| Eurofins Scientific | 25.78% | -12.14% | 1.43% | -78.19% | -26.87% | -26.87% |
Performance & Financial Health Analysis: Predilife S.A vs Eurofins Scientific
| Metric | ALPRE | ERF |
|---|---|---|
| Market Information | ||
| Market Cap | €12.80M | €11.98B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 499 | 324,409 |
| 90 Day Avg. Volume | 890 | 283,538 |
| Last Close | €3.38 | €66.46 |
| 52 Week Range | €3.01 - €5.85 | €44.52 - €69.40 |
| % from 52W High | -42.22% | -4.24% |
| All-Time High | €24.00 (Apr 29, 2024) | €620.20 (May 25, 2020) |
| % from All-Time High | -85.92% | -89.28% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.35% | 0.06% |
| Quarterly Earnings Growth | N/A | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.98% | 0.06% |
| Operating Margin (TTM) | -5.58% | 0.13% |
| Return on Equity (TTM) | -46.54% | 0.09% |
| Debt to Equity (MRQ) | -1.16 | 88.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-3.50 | €19.28 |
| Cash per Share (MRQ) | €0.38 | €4.23 |
| Operating Cash Flow (TTM) | €-3,721,481 | €1.31B |
| Levered Free Cash Flow (TTM) | €-2,753,089 | €685.29M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.82% |
| Last 12-Month Dividend | N/A | €1.10 |
Valuation & Enterprise Metrics Analysis: Predilife S.A vs Eurofins Scientific
| Metric | ALPRE | ERF |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 28.82 |
| Forward P/E | -2.21 | 18.85 |
| PEG Ratio | N/A | 18.85 |
| Price to Sales (TTM) | 25.95 | 1.68 |
| Price to Book (MRQ) | N/A | 3.39 |
| Market Capitalization | ||
| Market Capitalization | €12.80M | €11.98B |
| Enterprise Value | €16.51M | €14.89B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 33.47 | 2.08 |
| Enterprise to EBITDA | -4.14 | 10.41 |
| Risk & Other Metrics | ||
| Beta | 0.38 | 0.77 |
| Book Value per Share (MRQ) | €-3.50 | €19.28 |
Financial Statements Comparison: Predilife S.A vs Eurofins Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALPRE | ERF |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALPRE | ERF |
|---|---|---|
| Cash & Equivalents | €1.06M | €613.90M |
| Total Current Assets | €1.99M | €2.45B |
| Total Current Liabilities | €1.69M | €2.11B |
| Long-Term Debt | €4.45M | €3.13B |
| Total Shareholders Equity | €-4.27M | €5.38B |
| Retained Earnings | €-4.26M | €2.69B |
| Property, Plant & Equipment | €18,660 | €86.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALPRE | ERF |
|---|---|---|
| Operating Cash Flow | N/A | €33.15M |
| Capital Expenditures | N/A | €-16.72M |
| Free Cash Flow | N/A | €31.64M |
| Debt Repayment | N/A | €-1.30M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALPRE | ERF |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 499 | 324,409 |
| Average Daily Volume (90 Day) | 890 | 283,538 |
| Shares Outstanding | 3.78M | 186.78M |
| Float Shares | N/A | 114.29M |
| % Held by Insiders | 0.72% | 0.35% |
| % Held by Institutions | 0.00% | 0.33% |
Dividend Analysis & Yield Comparison: Predilife S.A vs Eurofins Scientific
| Metric | ALPRE | ERF |
|---|---|---|
| Last 12-Month Dividend | N/A | €1.10 |
| Last 12-Month Dividend Yield | N/A | 1.82% |
| 3-Year Avg Annual Dividend | N/A | €1.03 |
| 3-Year Avg Dividend Yield | N/A | 1.29% |
| 3-Year Total Dividends | N/A | €3.10 |
| Ex-Dividend Date | N/A | Apr 28, 2025 |